Does KETOPROFEN Cause Hypertransaminasaemia? 23 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Hypertransaminasaemia have been filed in association with KETOPROFEN (Orudis). This represents 0.4% of all adverse event reports for KETOPROFEN.
23
Reports of Hypertransaminasaemia with KETOPROFEN
0.4%
of all KETOPROFEN reports
1
Deaths
18
Hospitalizations
How Dangerous Is Hypertransaminasaemia From KETOPROFEN?
Of the 23 reports, 1 (4.3%) resulted in death, 18 (78.3%) required hospitalization, and 1 (4.3%) were considered life-threatening.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for KETOPROFEN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does KETOPROFEN Cause?
Pain (595)
Headache (574)
Hypersensitivity (556)
Erythema (546)
Acute kidney injury (517)
Hyperhidrosis (516)
Hepatic enzyme increased (508)
Asthma (507)
Rheumatoid arthritis (493)
Immunodeficiency (492)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which KETOPROFEN Alternatives Have Lower Hypertransaminasaemia Risk?
KETOPROFEN vs KETOPROFEN LYSINE
KETOPROFEN vs KETOROLAC TROMETHAMINE
KETOPROFEN vs KETOROLAC\KETOROLAC TROMETHAMINE
KETOPROFEN vs KETOTIFEN
KETOPROFEN vs KLONOPIN